Document:

Exhibit 4.4

   

  WARRANT AGREEMENT

   

  THIS WARRANT AGREEMENT (this “Agreement”), dated as of June [●], 2021, is by and between Riverview Acquisition Corp., a Delaware corporation (the “Company”),
      and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”, and also referred to herein as the “Transfer Agent”).

   

  WHEREAS, the Company is engaged in an initial public offering (the “Offering”)

      of units of the Company’s equity securities, each such unit comprised of one share of Class A common stock of the Company, par value $0.001 per share (“Common Stock”), and one-half of one Public Warrant (as defined below) (the “Units”)

      and, in connection therewith, has determined to issue and deliver up to 12,500,000 warrants (or up to 14,375,000 warrants if the Over-allotment Option (as defined below) is exercised in full) to public investors in the Offering (the “Public
          Warrants”);

   

  WHEREAS, the Company has entered into that certain Private Placement
      Warrants Purchase Agreement (the “Private Placement Warrants Purchase Agreement”) with Riverview Sponsor Partners, LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase
      an aggregate of 7,400,000 warrants simultaneously with the closing of the Offering bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”) at a purchase price of $1.00 per Private Placement Warrant;

   

  WHEREAS, in order to finance the Company’s transaction costs in
      connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or the Company’s officers and directors may, but are not obligated to, loan to the Company funds as the Company may require, of
      which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 warrants at a price of $1.00 per warrant (the “Working Capital Warrants”);

   

  WHEREAS, the Company has filed with the U.S. Securities and Exchange
      Commission (the “Commission”) a registration statement on Form S-1, File No. 333-255116 (the “Registration Statement”), and prospectus (the “Prospectus”), for the registration, under the Securities Act of
      1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the Common Stock included in the Units;

   

  WHEREAS, following consummation of the Offering, the Company may issue
      additional warrants (the “Post-IPO Warrants” and, together with the Private Placement Warrants, the Working Capital Warrants and the Public Warrants, the “Warrants”) in connection with, or following the consummation by the
      Company of, a Business Combination;

   

  WHEREAS, each whole Warrant entitles the holder thereof to purchase one
      share of Common Stock for $11.50 per whole share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Public Warrants will not be able to exercise any fraction of a Warrant;

   

  

  
    1 

    
      
 

  

   

  WHEREAS, the Company desires the Warrant Agent to act on behalf of the
      Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants;

   

  WHEREAS, the Company desires to provide for the form and provisions of
      the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

   

  WHEREAS, all acts and things have been done and performed which are
      necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of
      this Agreement.

   

  NOW, THEREFORE, in consideration of the mutual agreements herein
      contained, the parties hereto agree as follows:

   

  1.          Appointment of Warrant Agent. The Company hereby
      appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

   

  2.             Warrants.

   

  2.1          Form of Warrant. Each Warrant shall be issued in
      registered form only, and, if a physical certificate is issued, shall be in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman
      of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the
      capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. All of the Public Warrants shall initially be represented by one
      or more book-entry certificates (each, a “Book-Entry Warrant Certificate”).

   

  2.2       Effect of Countersignature. If a physical certificate is
      issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

   

  2.3            Registration.

   

  2.3.1       Warrant Register. The Warrant Agent shall maintain
      books (the “Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names
      of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one or more Book-Entry Warrant
      Certificates deposited with The Depository Trust Company (the “Depositary”) and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants shall be shown on, and the
      transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depositary (each such institution, with respect to
      a Warrant in its account, a “Participant”).

   

  

  
    2 

    
      
 

  

   

  If the Depositary subsequently ceases to make its book-entry settlement system available for
      the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants
      available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to deliver to
      the Depositary definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificate”). Such Definitive Warrant Certificate shall be in the form annexed hereto as Exhibit A, with appropriate
      insertions, modifications and omissions, as provided above.

   

  2.3.2       Registered Holder. Prior to due presentment for
      registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant
      and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on a Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all
      other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

   

  2.4         Detachability of Warrants. The Common Stock and Public
      Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open
      for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with the consent of Cantor Fitzgerald & Co., as representative of the
      several underwriters, but in no event shall the Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed a current report on Form 8-K with the Commission containing an audited balance sheet
      reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering (the “Over-allotment
          Option”), if the Over-allotment Option is exercised prior to the filing of the Form 8-K, and (B) the Company issues a press release and files with the Commission a current report on Form 8-K announcing when such separate trading shall
      begin.

   

  2.5         Fractional Warrants. The Company shall not issue
      fractional Warrants other than as part of the Units, each of which is comprised of one share of Common Stock and one-half of one Public Warrant. If, upon the detachment of Public Warrants from Units or otherwise, a holder of Warrants would be
      entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number of Warrants to be issued to such holder.

   

  

  
    3 

    
      
 

  

   

  2.6           Private Placement Warrants and Working Capital Warrants.
      The Private Placement Warrants and the Working Capital Warrants shall be identical to the Public Warrants, except that so long as they are held by either the Sponsor or any Permitted Transferees (as defined below), as applicable, the Private
      Placement Warrants and the Working Capital Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (ii) may not be transferred, assigned or sold until the date that is thirty (30) days after the
      completion by the Company of an initial Business Combination (as defined below), and (iii) shall not be redeemable by the Company; provided, however, that in the case of (ii), the Private Placement Warrants and the Working Capital Warrants
      and any shares of Common Stock held by either the Sponsor or any officers or directors of the Company, or any Permitted Transferees, as applicable, and issued upon exercise of the Private Placement Warrants and the Working Capital Warrants may be
      transferred by the holders thereof:

   

  (a)             to the Company’s officers or directors, any affiliate or
      family member of any of the Company’s officers or directors, any affiliate of the Sponsor or to any members of the Sponsor or any of their affiliates;

   

  (b)            in the case of an individual, by gift to a member of such
      individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization;

   

  (c)             in the case of an individual, by virtue of laws of
      descent and distribution upon death of such person;

   

  (d)            in the case of an individual, pursuant to a qualified
      domestic relations order;

   

  (e)            by private sales or transfers made in connection with any
      forward purchase agreement or similar arrangement or in connection with the consummation of an initial Business Combination at prices no greater than the price at which the Warrants were originally purchased;

   

  (f)             by virtue of the laws of the State of Delaware or the
      limited liability company agreement of the Sponsor upon dissolution of the Sponsor;

   

  (g)             in the event of the Company’s liquidation prior to the
      consummation of a Business Combination; or

   

  (h)          in the event that, subsequent to the consummation of a
      Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other
      property; provided, however, that, in the case of clauses (a) through (f), these transferees (the “Permitted Transferees”) enter into a written agreement with the Company agreeing to be bound by the transfer restrictions in this
      Agreement and the other restrictions contained in the letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and the Company’s officers and directors.

   

  2.7           Working Capital Warrants. Each of the Working Capital
      Warrants shall be identical to the Private Placement Warrants.

   

  

  
    4 

    
      
 

  

   

  2.8           Post-IPO Warrants. The Post-IPO Warrants, when and if
      issued, shall have the same terms and be in the same form as the Public Warrants except as may be agreed upon by the Company.

   

  3.             Terms and Exercise of Warrants.

   

  3.1            Warrant Price. Each Warrant shall entitle the
      Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section

        4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in
      its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior written
      notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants.

   

  3.2            Duration of Warrants. A Warrant may be exercised
      only during the period (the “Exercise Period”) commencing on the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or
      similar business combination, involving the Company and one or more businesses (a “Business Combination”), and terminating on the earlier to occur of: (i) at 5:00 p.m., New York City time on the date that is five (5) years after the
      date on which the Company completes its initial Business Combination, (ii) the liquidation of the Company and (iii) other than with respect to the Private Placement Warrants and the Working Capital Warrants then held by either the Sponsor or any
      officers or directors of the Company, or any of their Permitted Transferees as provided in Section 6.1, the Redemption Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”); provided,
      however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration statement. Except with respect to the right
      to receive the Redemption Price (as defined below) in the event of a redemption (as set forth in Section 6 hereof), each outstanding Warrant (other than a Private Placement Warrant or a Working Capital Warrant held by either the Sponsor or
      any officers or directors of the Company, or their Permitted Transferees, in the event of a redemption for cash) not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this
      Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that the Company shall provide at least twenty
      (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

   

  

  
    5 

    
      
 

  

   

  3.3           Exercise of Warrants.

   

  3.3.1       Payment. Subject to the provisions of the Warrant
      and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a
      Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant Agent
      to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) shares of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the
      Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant in accordance with the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common
      Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

   

  (a)             in lawful money of the United States, in good certified
      check or good bank draft payable to the order of the Warrant Agent or by wire transfer of immediately available funds;

   

  (b)            in the event of a redemption pursuant to Section 6
      hereof in which the Company’s board of directors (the “Board”) has elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of Common Stock
      equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value”, as defined in this subsection 3.3.1(b), over the Warrant Price by
      (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b) and Section 6.3, the “Fair Market Value” shall mean the average closing price of the Common Stock for the ten (10) trading days ending on the third trading day
      prior to the date on which the notice of redemption is sent to the holders of the Warrants, pursuant to Section 6 hereof;

   

  (c)          with respect to any Private Placement Warrant or Working
      Capital Warrant, so long as such Private Placement Warrant or Working Capital Warrant is held by either the Sponsor or any officer or director of the Company, or their Permitted Transferees, by surrendering the Warrants for that number of shares of
      Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value”, as defined in this subsection 3.3.1(c), over the
      Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean the average closing price of the Common Stock for the ten (10) trading days ending on the third trading day prior
      to the date on which notice of exercise of the Private Placement Warrant or Working Capital Warrant is sent to the Warrant Agent; or

   

  (d)            as provided in Section 7.4 hereof.

   

  

  
    6 

    
      
 

  

   

  3.3.2       Issuance of Shares of Common Stock on Exercise. As
      soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1 (a)), the Company shall issue to the Registered Holder of such Warrant a
      book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been
      exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which such Warrant shall not have been exercised. If fewer than all the Warrants evidenced by a Book-Entry Warrant
      Certificate are exercised, a notation shall be made to the records maintained by the Depositary, its nominee for each Book-Entry Warrant Certificate, or a Participant, as appropriate, evidencing the balance of the Warrants remaining after such
      exercise. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under
      the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations under Section 7.4. No Warrant
      shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration
      or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such
      Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the
      shares of Common Stock underlying such Unit. In no event will the Company be required to net cash settle the Warrant exercise. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4.
      If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest
      whole number, the number of shares of Common Stock to be issued to such holder.

   

  3.3.3       Valid Issuance. All shares of Common Stock issued
      upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and non-assessable.

   

  3.3.4       Date of Issuance. Each person in whose name any
      book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position
      representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date
      when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the
      share transfer books or book-entry system are open.

   

  

  
    7 

    
      
 

  

   

  3.3.5       Maximum Percentage. A holder of a Warrant may notify
      the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such
      election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such
      person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify)(the “Maximum Percentage”) of the shares of Common
      Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of
      Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the
      Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without
      limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this
      paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares
      of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, current report on Form 8-K or other public filing with
      the Commission as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the
      written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common
      Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written
      notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase
      shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

   

  4.               Adjustments.

   

  4.1           Stock Dividends.

   

  4.1.1       Split-Ups. If after the date hereof, and subject to
      the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the
      effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering
      to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the
      number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the
      quotient of (x) the price per share of Common Stock paid in such rights offering and divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for
      Common Stock, in determining the price payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means the
      volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market,
      regular way, without the right to receive such rights.

   

  

  
    8 

    
      
 

  

   

  4.1.2       Extraordinary Dividends. If the Company, at any time
      while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital
      stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Common Stock in connection with
      a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (as amended from time to time,
      the “Charter”) to modify the substance or timing of the Company’s obligation to redeem 100% of the shares of Common Stock included in the Units sold in the Offering if the Company does not complete the Business Combination within the
      period set forth in the Charter or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, or to provide for redemption in connection with a Business Combination or (e) in
      connection with the redemption of public shares of Common Stock included in the Units sold in the Offering upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation
      (any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash
      and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary
          Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period
      ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in
      an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the Offering).

   

  4.2            Aggregation of Shares. If after the date hereof,
      and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event,
      then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in
      outstanding shares of Common Stock.

   

  

  
    9 

    
      
 

  

   

  4.3            Adjustments in Warrant Price.

   

  4.3.1       Whenever the number of shares of Common Stock purchasable
      upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by
      a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so
      purchasable immediately thereafter.

   

  4.3.2       If (x) the Company issues additional shares of Common Stock
      or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective
      issue price to be determined in good faith by the Board and, in the case of any such issuance to the initial stockholders (as defined in the Prospectus) or their affiliates, without taking into account any shares of Class B Common Stock (as defined
      below) held by such stockholders or their affiliates, as applicable, prior to such issuance (the “Newly Issued Price”)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and
      interest thereon, available for funding the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Common Stock during the 20 trading day period starting on the trading day prior to the day on
      which the Company consummates the Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the
      Newly Issued Price, and the last sales price of the Common Stock that triggers the Company’s right to redeem the Warrants pursuant to Section 6.1 below shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market
      Value and the Newly Issued Price.

   

  

  
    10 

    
      
 

  

   

  4.4            Replacement of Securities upon Reorganization, etc.
      In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such shares of
      Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company is the continuing corporation (and is
      not a subsidiary of another entity whose stockholders did not own all or substantially all of the Common Stock of the Company in substantially the same proportions immediately before such transaction) and that does not result in any reclassification
      or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the
      Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately
      theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or
      consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”);

      provided, however, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and
      amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock
      in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made
      by the Company in connection with redemption rights held by stockholders of the Company as provided for in the Charter or as a result of the redemption of shares of Common Stock by the Company if a proposed initial Business Combination is presented
      to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or
      any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such group of which any such
      affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive as the
      Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange
      offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as
      possible to the adjustments provided for in this Section 4; provided further that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the form of common stock in
      the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder
      properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced
      by an amount (in dollars) equal to the difference (but in no event less than zero) of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as
      defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial
      Markets (“Bloomberg”).

   

  For purposes of calculating such amount, (1) Section 6 of this Agreement shall be
      taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable
      event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free
      interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash,
      the amount of such cash per share of Common Stock, and (ii) in all other cases, the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the
      applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3
      and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to
      less than the par value per share issuable upon exercise of the Warrant.

   

  

  
    11 

    
      
 

  

   

  4.5            Notices of Changes in Warrant. Upon every
      adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
      and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
      Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such
      holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

   

  4.6            No Fractional Shares. Notwithstanding any provision
      contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be
      entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

   

  4.7            Form of Warrant. The form of Warrant need not be
      changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to
      this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant
      thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

   

  4.8            Other Events. In case any event shall occur
      affecting the Company as to which none of the provisions of the preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the
      Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing,
      which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms
      of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

   

  

  
    12 

    
      
 

  

   

  4.9            No Adjustment. For the avoidance of doubt, no
      adjustment shall be made to the terms of the Warrants solely as a result of an adjustment to the conversion ratio of the Company’s Class B common stock (the “Class B Common Stock”) into shares of Common Stock or the conversion of the
      shares of Class B Common Stock into shares of Common Stock, in each case, pursuant to the Charter.

   

  5.             Transfer and Exchange of Warrants.

   

  5.1            Registration of Transfer. The Warrant Agent shall
      register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, in the case of a certificated Warrant, properly endorsed with signatures properly guaranteed and accompanied
      by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the
      Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

   

  5.2            Procedure for Surrender of Warrants. Warrants may
      be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so
      surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise provided herein or in any Book-Entry Warrant Certificate or Definitive Warrant Certificate, each Book-Entry Warrant Certificate and
      Definitive Warrant Certificate may be transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further, however, that in the
      event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants and the Working Capital Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof
      until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

   

  5.3            Fractional Warrants. The Warrant Agent shall not be
      required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

   

  5.4            Service Charges. No service charge shall be made
      for any exchange or registration of transfer of Warrants.

   

  5.5            Warrant Execution and Countersignature. The Warrant
      Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant
      Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

   

  5.6            Transfer of Warrants. Prior to the Detachment Date,
      the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a
      Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the
      Detachment Date.

   

  

  
    13 

    
      
 

  

   

  6.             Redemption.

   

  6.1            Redemption of Warrants for Cash. Subject to Sections

        6.4 and 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to
      the Registered Holders of the Warrants, as described in Section 6.2 below, at the price of $0.01 per Warrant (the “Redemption Price”); provided that the closing price of the Common Stock reported has been at least $18.00
      per share (subject to adjustment in compliance with Section 4 hereof), on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third Business Day prior to the date on which notice of the redemption is
      given; provided further that there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period
      (as defined in Section 6.2 below) or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection 3.3.1 and such cashless exercise is exempt from registration under the Securities Act.

   

  6.2            Date Fixed for, and Notice of, Redemption. In the
      event that the Company elects to redeem all of the Warrants pursuant to Section 6.1, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage
      prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (such period, the “Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the
      registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder received such notice.

   

  6.3            Exercise After Notice of Redemption. The Warrants
      may be exercised, for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b) of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the
      Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1, the notice of redemption shall contain the information necessary to
      calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the “Fair Market Value” (as such term is defined in subsection 3.3.1(b) hereof) in such case. On and after the Redemption Date, the record
      holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

   

  6.4            Exclusion of Certain Warrants. The Company agrees
      that the redemption rights provided in Section 6.1 shall not apply to the Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants (if such Post-IPO Warrants provide that they are non-redeemable by the Company) if at
      the time of the redemption such Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants continue to be held by the Sponsor or any Permitted Transferees, as applicable. However, once such Private Placement Warrants, Working Capital
      Warrants or Post-IPO Warrants are transferred (other than to Permitted Transferees under Section 2.6), the Company may redeem the Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants (if the Post-IPO Warrants
      permit such redemption by their terms) pursuant to Section 6.1 hereof, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants, Working Capital Warrants or Post-IPO
      Warrants to exercise the Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants prior to redemption pursuant to Section 6.1. The Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants (if
      such Post-IPO Warrants provide that they are non-redeemable by the Company) that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants, Working Capital Warrants or Post-IPO
      Warrants and shall become Public Warrants under this Agreement.

   

  

  
    14 

    
      
 

  

   

  7.             Other Provisions Relating to Rights of Holders of
        Warrants.

   

  7.1            No Rights as Stockholder. A Warrant does not
      entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive
      notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

   

  7.2         Lost, Stolen, Mutilated, or Destroyed Warrants. If any
      Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender
      thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
      stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

   

  7.3            Reservation of Common Stock. The Company shall at
      all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

   

  7.4            Registration of Common Stock; Cashless Exercise at
        Company’s Option.

   

  7.4.1       Registration of the Common Stock. The Company agrees
      that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing of its initial Business Combination, it shall use its best efforts to file with the Commission a registration statement registering, under the
      Securities Act, the issuance of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a
      current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following the closing of the
      Business Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the
      Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by
      exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of
      shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value”
      shall mean the average closing price of the Common Stock for the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities
      broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request,
      provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this subsection 7.4.1 is

      not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in
      Rule 144 under the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of
      the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

   

  

  
    15 

    
      
 

  

   

  7.4.2       Cashless Exercise at Company’s Option. If the Common
      Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor rule), the Company may, at its
      option, require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as described in subsection 7.4.1
      and (i) in the event the Company so elects, the Company shall not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable upon exercise of the Warrants,
      notwithstanding anything in this Agreement to the contrary or (ii) if the Company does not so elect, the Company agrees to use its best efforts to register or qualify for sale the Common Stock issuable upon exercise of the Public Warrants under the
      blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption is not available.

   

  8.             Concerning the Warrant Agent and Other Matters.

   

  8.1            Payment of Taxes. The Company shall from time to
      time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any
      transfer taxes in respect of the Warrants or such shares of Common Stock.

   

  

  
    16 

    
      
 

  

   

  8.2           Resignation, Consolidation, or Merger of Warrant Agent.

   

  8.2.1       Appointment of Successor Warrant Agent. The Warrant
      Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes
      vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has
      been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the
      Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized
      and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to
      supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as
      if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
      transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
      instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

   

  8.2.2       Notice of Successor Warrant Agent. In the event a
      successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

   

  8.2.3       Merger or Consolidation of Warrant Agent. Any
      corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this
      Agreement without any further act.

   

  8.3           Fees and Expenses of Warrant Agent.

   

  8.3.1       Remuneration. The Company agrees to pay the Warrant
      Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in
      the execution of its duties hereunder.

   

  8.3.2       Further Assurances. The Company agrees to perform,
      execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of
      the provisions of this Agreement.

   

  

  
    17 

    
      
 

  

   

  8.4           Liability of Warrant Agent.

   

  8.4.1       Reliance on Company Statement. Whenever in the
      performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless
      other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice
      President, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

   

  8.4.2       Indemnity. The Warrant Agent shall be liable
      hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything
      done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

   

  8.4.3       Exclusions. The Warrant Agent shall have no
      responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant
      or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such
      adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock
      to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

   

  8.5            Acceptance of Agency. The Warrant Agent hereby
      accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account
      for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

   

  8.6            Waiver. The Warrant Agent has no right of set-off
      or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the
      Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims
      against the Trust Account and any and all rights to seek access to the Trust Account.

   

  

  
    18 

    
      
 

  

   

  9.             Miscellaneous Provisions.

   

  9.1            Successors. All the covenants and provisions of
      this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

   

  9.2            Notices. Any notice, statement or demand authorized
      by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service
      within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

   

  Riverview Acquisition Corp.

      510 South Mendenhall Road, Suite 200,

      Memphis, TN 38117

      Attention: R. Brad Martin, Chairman and Chief Executive Officer

   

  Any notice, statement or demand authorized by this Agreement to be given or made by the
      holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such
      notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

   

  Continental Stock Transfer & Trust Company

      1 State Street, 30th Floor

      New York, NY 10004

      Attention: Compliance Department

   

  in each case, with copies to:

   

  King & Spalding LLP

      1185 Avenue of the Americas, 34th Floor

      New York, NY 10036

      Attn: Keith Townsend

      Email: ktownsend@kslaw.com

   

  and

  Ellenoff Grossman & Schole LLP

      1345 Avenue of the Americas, 11th Floor

      New York, NY 10105

      Attn: Douglas S. Ellenoff, Esq.

      Stuart Neuhauser, Esq.

      Email: ellenoff@egsllp.com

      sneuhauser@egsllp.com

   

  9.3            Applicable Law and Exclusive Forum. The validity,
      interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any
      way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be the
      exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such jurisdiction and that such courts represent an inconvenient forum.

   

  

  
    19 

    
      
 

  

   

  Notwithstanding the foregoing, the provisions of this paragraph will not
      apply to suits brought to enforce any liability or duty created by the Exchange Act, any other claim for which the federal district courts of the United States of America are the sole and exclusive forum or any complaint asserting a cause of action
      arising under the Securities Act against us or any of our directors, officers, other employees or agents.

   

  Any person or entity purchasing or otherwise acquiring any interest in
      the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court
      located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the
      personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum
      provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

   

  9.4            Persons Having Rights under this Agreement. Nothing
      in this Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant,
      condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and
      of the Registered Holders of the Warrants.

   

  9.5            Examination of the Warrant Agreement. A copy of
      this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such
      holder to submit such holder’s Warrant for inspection by the Warrant Agent.

   

  9.6            Counterparts. This Agreement may be executed in any
      number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

   

  9.7           Effect of Headings. The section headings herein are
      for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

   

  9.8            Amendments. This Agreement may be amended by the
      parties hereto without the consent of any Registered Holder (i) for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to
      matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders, and (ii) to provide for the delivery of Alternative Issuance
      pursuant to Section 4.4. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise Period shall require the vote or written consent of the Registered Holders of 50% of the
      number of the then outstanding Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants or any provision of this Agreement with respect to the Private
      Placement Warrants, Working Capital Warrants or Post-IPO Warrants, 50% of the number of then outstanding Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price
      or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders.

   

  

  
    20 

    
      
 

  

   

  9.9            Severability. This Agreement shall be deemed
      severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
      term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

   

  [Signature Page Follows]

   

  
    21 

    
      
 

  

   

  IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
      duly executed as of the date first above written.

   

  

  	 	RIVERVIEW ACQUISITION CORP.
	 	 
	 	By:	
	 	Name: R. Brad Martin
	 	Title: Chairman and Chief Executive Officer
	 	 	 
	 	CONTINENTAL STOCK TRANSFER &
	 	TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	
	 	Name:
	 	Title:

   

  

  [Signature Page to Warrant Agreement – Riverview Acquisition Corp.]

   

  
      

    
      
 

  

  
   

  EXHIBIT A

      Form of Warrant Certificate

      [FACE]

   

  Number

   

  Warrants

      THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

      THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

      IN THE WARRANT AGREEMENT DESCRIBED BELOW RIVERVIEW ACQUISITION CORP.

      Incorporated Under the Laws of the State of Delaware

   

  CUSIP: 759395 112

  Warrant Certificate

   

  This Warrant Certificate certifies that ________________,
      or registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock, $0.001 par value per share (“Class A Common Stock”),

      of Riverview Acquisition Corp., a Delaware corporation (the “Company”). Each whole Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company that
      number of fully paid and non-assessable shares of Class A Common Stock as set forth below, at the exercise price (the “Warrant Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless
          exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Warrant Price at the office or agency of the Warrant Agent referred to below, subject to the
      conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

   

  Each whole Warrant is initially exercisable for one fully paid and
      non-assessable share of Class A Common Stock. No fractional shares will be issued upon exercise of any Warrant. If, upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Class A Common Stock, the
      Company will, upon exercise, round down to the nearest whole number the number of shares of Class A Common Stock to be issued to the Warrant holder. The number of shares of Class A Common Stock issuable upon exercise of the Warrants is subject to
      adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

   

  The initial Warrant Price per share of Class A Common Stock for any
      Warrant is equal to $11.50 per share. The Warrant Price is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

   

  Subject to the conditions set forth in the Warrant Agreement, the
      Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant
      Agreement.

   

  

  
    A-1 

    
      
 

  

   

  Reference is hereby made to the further provisions of this Warrant
      Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this place.

   

  This Warrant Certificate shall not be valid unless countersigned by the
      Warrant Agent, as such term is used in the Warrant Agreement.

   

  This Warrant Certificate shall be governed by and construed in
      accordance with the internal laws of the State of New York.

   

  

  	 	RIVERVIEW ACQUISITION CORP.
	 	 
	 	By:	
	 	Name: R. Brad Martin
	 	Title: Chairman and Chief Executive Officer
	 	 	 
	 	CONTINENTAL STOCK TRANSFER &
	 	TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	
	 	Name:
	 	Title:

   

  
    A-2 

    
      
 

  

   

  [Form of Warrant Certificate]

      [Reverse]

   

  The Warrants evidenced by this Warrant Certificate are part of a duly
      authorized issue of Warrants entitling the holder on exercise to receive shares of Class A Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of June [__], 2021 (the “Warrant Agreement”), duly executed
      and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this
      instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
      meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not
      defined herein shall have the meanings given to them in the Warrant Agreement.

   

  Warrants may be exercised at any time during the Exercise Period set
      forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together
      with payment of the Warrant Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of
      Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of
      Warrants not exercised.

   

  Notwithstanding anything else in this Warrant Certificate or the Warrant
      Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the shares of Class A Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating
      to the shares of Class A Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

   

  The Warrant Agreement provides that upon the occurrence of certain
      events the number of shares of Class A Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a
      fractional interest in a share of Class A Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Class A Common Stock to be issued to the holder of the Warrant.

   

  Warrant Certificates, when surrendered at the principal corporate trust
      office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
      payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants.

   

  

  
    A-3 

    
      
 

  

   

  Upon due presentation for registration of transfer of this Warrant
      Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate,
      subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith.

   

  The Company and the Warrant Agent may deem and treat the Registered
      Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all
      other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

   

  
    A-4 

    
      
 

  

   

  Election to Purchase

      (To Be Executed Upon Exercise of Warrant)

   

  The undersigned hereby irrevocably elects to exercise the right,
      represented by this Warrant Certificate, to receive _____ shares of Class A Common Stock and herewith tenders payment for such shares of Class A Common Stock to the order of Riverview Acquisition Corp. (the “Company”) in the amount of
      $_____________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Class A Common Stock be registered in the name of _____________, whose address is and that such shares of Class A Common Stock be
      delivered to ______________ whose address is _______________. If said number of shares of Class A Common Stock is less than all of the shares of Class A Common Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate
      representing the remaining balance of such shares of Class A Common Stock be registered in the name of ___________________, whose address is _______________ and that such Warrant Certificate be delivered to _______________, whose address is
      _______________.

   

  In the event that the Warrant has been called for redemption by the
      Company pursuant to Section 6.1 of the Warrant Agreement and the Company has required cashless exercise pursuant to Section 6.3 of the Warrant Agreement, the number of shares of Class A Common Stock that this Warrant is exercisable
      for shall be determined in accordance with subsection 3.3.1(b) and Section 6.3 of the Warrant Agreement.

   

  In the event that the Warrant is a Private Placement Warrant or a
      Working Capital Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of shares of Class A Common Stock that this Warrant is exercisable for shall be determined in
      accordance with subsection 3.3.1(c) of the Warrant Agreement.

   

  In the event that the Warrant is to be exercised on a “cashless” basis
      pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Class A Common Stock that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

   

  In the event that the Warrant may be exercised, to the extent allowed by
      the Warrant Agreement, through cashless exercise (i) the number of shares of Class A Common Stock that this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless
      exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive
      shares of Class A Common Stock. If said number of shares of Class A Common Stock is less than all of the shares of Class A Common Stock purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant
      Certificate representing the remaining balance of such shares of Class A Common Stock be registered in the name of ________________, whose address is________________ and that such Warrant Certificate be delivered to ________________, whose address is
      ________________.

   

  [Signature Page Follows]

   

  
    A-5 

    
      
 

  

   

  Date: June [__], 2021 

  

  	 	 
	 	Signature
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Tax Identification Number)

   

  Signature Guaranteed:

   

    

   

  
    

  THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
    SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).
   

  
      

    
      
 

  

  
   

  EXHIBIT B

      LEGEND

   

  “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
      EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG RIVERVIEW ACQUISITION CORP. (THE “COMPANY”), RIVERVIEW SPONSOR PARTNERS, LLC AND THE OTHER PARTIES
      THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT
      AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

   

  SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY
      ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

   

  
    B-1tptw_ex1047

 

COMMON STOCK PURCHASE AGREEMENT

 

 

 

This Common Stock Purchase Agreement is entered
into effective as of this 28th
day of May, 2021 (this
“Agreement”),
by and between TPT Global Tech, Inc., a Florida
corporation

 

(the “Company”),
and WHITE LION CAPITAL LLC, a Nevada limited liability company (the
“Investor”).

 

 

WHEREAS, the parties desire that, upon the terms and
subject to the conditions contained herein, the Investor shall
purchase, from time to time, as provided herein, and the Company
shall issue and sell up to Five Million Dollars ($5,000,000) of the
Company’s Common Stock (as defined
below).

 

NOW,
THEREFORE, the parties hereto
agree as follows:

 

 

 

ARTICLE I CERTAIN DEFINITIONS

 

            Section
1.1. DEFINED
TERMS. As used in this
Agreement, the following terms shall have the following meanings
specified or indicated (such meanings to be equally applicable to
both the singular and plural forms of the terms
defined):

 

“Agreement”
shall have the meaning specified in the preamble
hereof.

 

“Average Daily Trading
Volume” shall mean the
median daily trading volume of the Company’s Common Stock
over the most recent five (5) Business Days prior to the respective
Purchase Date, as reported by Bloomberg.

 

“Bankruptcy
Law” means Title 11, U.S.
Code, or any similar federal or state law for the relief of
debtors.

 

“Beneficial Ownership
Limitation” shall have
the meaning specified in Section
7.2(h).

 

“Business
Day” shall mean a day on
which the Principal Market shall be open for
business.

 

“Claim
Notice” shall have the
meaning specified in Section
9.3(a).

 

“Clearing
Costs” shall mean $3,000
to cover the Investor’s broker and Transfer Agent costs with
respect to each deposit of the Purchase Notice
Shares.

 

 

 

 

“Closing”
shall mean the closing of a purchase and sale of shares of Common
Stock pursuant to Section 2.2.

 

“Closing
Date” shall have the
meaning specified in Section
2.2(b).

 

“Commitment
Amount” shall mean Five
Million Dollars ($5,000,000).

 

“Commitment
Period” shall mean the
period commencing on the Execution Date and ending on the earlier
of (i) the date on which the Investor shall have purchased a number
of Purchase Notice Shares pursuant to this Agreement equal to the
Commitment Amount or (ii) December 31, 2021.

 

“Common
Stock” shall mean the
Company’s common stock, $0.001 par value per share, and any
shares of any other class of common stock whether now or hereafter
authorized, having the right to participate in the distribution of
dividends (as and when declared) and assets (upon liquidation of
the Company).

 

“Common Stock
Equivalents” means any
securities of the Company entitling the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt,
preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or
otherwise entitles the holder thereof to receive, Common
Stock.

 

“Company”
shall have the meaning specified in the preamble to this
Agreement.

 

“Custodian”
means any receiver, trustee, assignee, liquidator or similar
official under any Bankruptcy Law.

 

“Current
Report” has the meaning
set forth in Section
6.2.

 

“Damages”
shall mean any loss, claim, damage, liability, cost and expense
(including, without limitation, reasonable attorneys’ fees
and disbursements and costs and expenses of expert witnesses and
investigation).

 

“Disclosure
Schedules” means the
Disclosure Schedules of the Company delivered concurrently
herewith.

 

 

 

 

“DTC” shall mean The Depository Trust Company,
or any successor performing substantially the same function for the
Company.

 

“DTC/FAST
Program” shall mean the
DTC’s Fast Automated Securities Transfer
Program.

 

“DWAC”
shall mean Deposit Withdrawal at Custodian as defined by the
DTC.

 

“DWAC
Eligible” shall mean that
(a) the Common Stock is eligible at DTC for full services pursuant
to DTC’s Operational Arrangements, including, without
limitation, transfer through DTC’s DWAC system, (b) the
Company has been approved (without revocation) by the DTC’s
underwriting department, (c) the Transfer Agent is approved as an
agent in the DTC/FAST Program, (d) the Purchase Notice Shares are
otherwise eligible for delivery via DWAC, and (e) the Transfer
Agent does not have a policy prohibiting or limiting delivery of
the Purchase Notice Shares, as applicable, via
DWAC.

 

“DWAC
Shares” means shares of
Common Stock that are (i) issued in electronic form, (ii) freely
tradable and transferable and without restriction on resale and
(iii) timely credited by the Company to the Investor’s or its
designee’s specified DWAC account with DTC under the DTC/FAST
Program, or any similar program hereafter adopted by DTC performing
substantially the same function.

 

“Exchange
Act” shall mean the
Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.

 

“Execution
Date” shall mean the date
of this Agreement.

 

“Fixed
Purchase” shall mean a
purchase and sale of Common Stock whereby the Company and Investor
agree in writing to a negotiated purchase of Common Stock as
outlined in Exhibit B; provided that Company has submitted at least
one Purchase Notice.

 

“Indemnified
Party” shall have the
meaning specified in Section
9.2.

 

“Indemnifying
Party” shall have the
meaning specified in Section
9.2.

 

“Indemnity
Notice” shall have the
meaning specified in Section
9.3(b).

 

“Investment
Amount” shall mean the
Purchase Notice Amount less Clearing Costs.

 

“Investment
Limit” shall mean
$1,000,000 initially, subject to increase at the sole discretion of
the Investor.

 

 

 

 

“Investor”
shall have the meaning specified in the preamble to this
Agreement.

 

“Lien”
means a lien, charge, pledge, security interest, encumbrance, right
of first refusal, preemptive right or other
restriction.

 

“Material Adverse
Effect” shall mean any
effect on the business, operations, properties, or financial
condition of the Company that is material and adverse to the
Company and/or any condition, circumstance, or situation that would
prohibit or otherwise materially interfere with the ability of the
Company to enter into and perform its obligations under any
Transaction Document.

 

“Person”
shall mean an individual, a corporation, a partnership, an
association, a trust or other entity or organization, including a
government or political subdivision or an agency or instrumentality
thereof.

 

“Principal
Market” shall mean any of
the national exchanges (i.e. NYSE, AMEX, Nasdaq), or principal
quotation systems (i.e. OTCQX, OTCQB, OTC Pink, the OTC Bulletin
Board), or other principal exchange or recognized quotation system
which is at the time the principal trading platform or market for
the Common Stock.

 

“Purchase
Amount” means a dollar
amount equal to the closing price of the Common Stock on the
Purchase Date multiplied by the number of shares listed in the
respective Purchase Notice, not to exceed the Investment
Limit.

 

“Purchase
Date” shall have the
meaning specified in Section
2.2(a).

 

“Purchase
Notice” shall mean a
written notice from Company, substantially in the form of
Exhibit
A hereto, to the Investor
setting forth the Purchase Notice Shares which the Company requires
the Investor to purchase pursuant to the terms of this
Agreement.

 

“Purchase Notice
Amount” shall mean the
Purchase Notice Shares referenced in the Purchase Notice multiplied
by the Purchase Price.

 

“Purchase Notice
Date” shall mean the
Business Day on which the Investor receives the DWAC Shares set
forth in the Purchase Notice in its brokerage
account.

 

“Purchase Notice
Limit” shall mean the
maximum amount of Purchase Notice Shares the Company may request
the Investor to purchase per each Purchase Notice shall be the
lesser of: (i) 200% of the Average Daily Trading Volume or (ii) the
Investment Limit divided by the highest closing price of the Common
Stock over the most recent five (5) Business Days including the
respective Purchase Date. Notwithstanding the forgoing, the
Investor may waive the Purchase Notice Limit at any time to allow
the Investor to purchase additional shares under a Purchase
Notice.

 

 

 

 

“Purchase Notice
Shares” shall mean all
shares of Common Stock that the Company shall be entitled to issue
as set forth in all Purchase Notices in accordance with the terms
and conditions of this Agreement.

 

“Purchase
Price” shall mean 85% of
the lowest daily VWAP of the Common Stock during the Valuation
Period.

 

“Registration Rights
Agreement” means the
registration rights agreement to be entered into by and among the
Company and the Investor, in the form set forth in
Exhibit
C. “Registration
Statement” shall have the
meaning specified in Section
6.2.

 

“Regulation
D” shall mean Regulation
D promulgated under the Securities Act.

 

“Restricted
Shares” shall have the
meaning set forth in Section
2.3.

 

“Rule
144” shall mean Rule 144
under the Securities Act or any similar provision then in force
under the Securities Act.

 

“SEC” shall mean the United States Securities
and Exchange Commission.

 

“SEC
Documents” shall have the
meaning specified in Section
4.5.

 

“Securities”
mean the Purchase Notice Shares to be issued to the Investor
pursuant to the terms of this Agreement.

 

“Securities
Act” shall mean the
Securities Act of 1933, as amended.

 

“Subsidiary”
means any Person the Company wholly-owns or controls, or in which
the Company, directly or indirectly, owns a majority of the voting
stock or similar voting interest, in each case that would be
disclosable pursuant to Item 601(b)(21) of Regulation S-K
promulgated under the Securities Act.

 

“Transaction
Documents” shall mean
this Agreement, the Registration Rights Agreement and all schedules
and exhibits hereto and thereto.

 

“Transfer
Agent” shall mean the
current transfer agent of the Company, and any successor transfer
agent of the Company.

 

“Valuation
Period” shall mean the
five (5) Business days prior to the Closing
Date.

 

 

 

 

 “VWAP”
means, for any security as of any date, the dollar volume-weighted
average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such
security, then on the principal securities exchange or securities
market on which such security is then traded), during the period
beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New
York time, as reported by Bloomberg through its “VAP”
function (set to 09:30 start time and 16:00 end time) or, if the
foregoing does not apply, the dollar volume-weighted average price
of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at
9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg, or, if no dollar volume-weighted average
price is reported for such security by Bloomberg for such hours,
the average of the highest closing bid price and the lowest closing
ask price of any of the market makers for such security as reported
in the “pink sheets” by OTC Markets Group Inc.
(formerly Pink Sheets LLC). If the VWAP cannot be calculated for
such security on such date on any of the foregoing bases, the VWAP
of such security on such date shall be the fair market value as
mutually determined by the Company and the Investor. If the Company
and the Investor are unable to agree upon the fair market value of
such security, then such dispute shall be resolved in accordance
with the procedures in Section 10.16. All such determinations shall
be appropriately adjusted for any share dividend, share split,
share combination, recapitalization or other similar transaction
during such period.

 

ARTICLE II PURCHASE AND SALE OF COMMON STOCK

 

Section 2.1 PURCHASE
NOTICES. Upon the terms and
conditions set forth herein (including, without limitation, the
provisions of Article VII), the Company shall have the right, but
not the obligation, to direct the Investor, by its delivery to the
Investor of a Purchase Notice from time to time, to purchase
Purchase Notice Shares provided that the amount of Purchase Notice
Shares shall not exceed the Purchase Notice Limit or the Beneficial
Ownership

 

Limitation set forth in Section 7.2(h). The Company may not deliver
a subsequent Purchase Notice until the Closing of an active
Purchase Notice, unless waived by Investor in writing.
Notwithstanding the forgoing, the Company may not submit a Purchase
Notice to the Investor if the Purchase Amount is less than $30,000.
In addition, the Company and the Investor may negotiate a Fixed
Purchase and in such case, the Company shall deliver the Fixed
Purchase Notice to the Investor, to direct the Investor to purchase
certain number of Purchase Notice Shares at a price as agreed to by
the parties.

 

            Section
2.2 MECHANICS.

 

 (a) 
PURCHASE
NOTICE. At any time and from
time to time during the
Commitment Period, except as provided in this Agreement, the
Company may deliver a Purchase Notice to Investor, subject to
satisfaction of the conditions set forth in Section 7.2 and
otherwise provided herein. The Company shall deliver the Purchase
Notice Shares as DWAC Shares to the Investor alongside delivery of
the Purchase Notice. A Purchase Notice shall be deemed delivered on
(i) the Business Day it is received by email by the Investor if
such notice is received on or prior to 4:00 p.m. New York time or
(ii) the next Business Day if it is received by email after 4:00
p.m. New York time on a Business Day or at any time on a day which
is not a Business
Day (the “Purchase Date”).

 

 (b) 
CLOSING.
The Closing of a Purchase Notice shall occur five (5)
Business
Day after the Purchase Notice Date (the “Closing
Date”); whereby the Investor shall deliver to the Company, by
5:00 p.m. New York time the applicable Investment Amount by wire
transfer of immediately available funds to an account designated by
the Company.

 

ARTICLE III REPRESENTATIONS AND WARRANTIES OF INVESTOR

 

The
Investor represents and warrants to the Company that:

 

Section 3.1 INTENT.
The Investor is entering into this Agreement for its own account
and the Investor has no present arrangement (whether or not legally
binding) at any time to sell the Securities to or through any
Person in violation of the Securities Act or any applicable state
securities laws; provided,
however,
that the Investor reserves the right to dispose of the Securities
at any time in accordance with federal and state securities laws
applicable to such disposition.

 

 

 

 

Section 3.2 NO
LEGAL ADVICE FROM THE COMPANY.
The Investor acknowledges that it has had the opportunity to review
this Agreement and the transactions contemplated by this Agreement
with its own legal counsel and investment and tax advisors. The
Investor is relying solely on such counsel and advisors and not on
any statements or representations of the Company or any of its
representatives or agents for legal, tax or investment advice with
respect to this investment, the transactions contemplated by this
Agreement or the securities laws of any
jurisdiction.

 

Section 3.3 ACCREDITED
INVESTOR. The Investor is an
accredited investor as defined in Rule 501(a)(3) of Regulation D,
and the Investor has such experience in business and financial
matters that it is capable of evaluating the merits and risks of an
investment in the Securities. The Investor acknowledges that an
investment in the Securities is speculative and involves a high
degree of risk.

 

Section 3.4 AUTHORITY.
The Investor has the requisite power and authority to enter into
and perform its obligations under the Transaction Documents and to
consummate the transactions contemplated hereby and thereby. The
execution and delivery of the Transaction Documents and the
consummation by it of the transactions contemplated hereby and
thereby have been duly authorized by all necessary action and no
further consent or authorization of the Investor is required. The
Transaction Documents to which it is a party has been duly executed
by the Investor, and when delivered by the Investor in accordance
with the terms hereof, will constitute the valid and binding
obligation of the Investor enforceable against it in accordance
with its terms, subject to applicable bankruptcy, insolvency, or
similar laws relating to, or affecting generally the enforcement
of, creditors’ rights and remedies or by other equitable
principles of general application.

 

Section 3.5 NOT
AN AFFILIATE. The Investor is
not an officer, director or “affiliate”
(as that term is defined in Rule 405 of the Securities Act) of the
Company.

 

Section 3.6 ORGANIZATION
AND STANDING. The Investor is
an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or
formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and
to consummate the transactions contemplated by the Transaction
Documents.

 

Section 3.7 ABSENCE
OF CONFLICTS. The execution and
delivery of the Transaction Documents and the consummation of the
transactions contemplated hereby and thereby and compliance with
the requirements hereof and thereof, will not (a) violate any law,
rule, regulation, order, writ, judgment, injunction, decree or
award binding on the Investor, (b) violate any provision of any
indenture, instrument or agreement to which the Investor is a party
or is subject, or by which the Investor or any of its assets is
bound, or conflict with or constitute a material default
thereunder, (c) result in the creation or imposition of any lien
pursuant to the terms of any such indenture, instrument or
agreement, or constitute a breach of any fiduciary duty owed by the
Investor to any third party, or (d) require the approval of any
third-party (that has not been obtained) pursuant to any material
contract, instrument, agreement, relationship or legal obligation
to which the Investor is subject or to which any of its assets,
operations or management may be subject.

 

Section 3.8 DISCLOSURE;
ACCESS TO INFORMATION. The
Investor had an opportunity to review copies of the SEC Documents
filed on behalf of the Company and has had access to all publicly
available information with respect to the
Company.

 

Section 3.9 MANNER
OF SALE. At no time was the
Investor presented with or solicited by or through any leaflet,
public promotional meeting, television advertisement or any other
form of general solicitation or advertising.

 

 

 

 

ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE
COMPANY

 

Except as set forth in the SEC Documents and the Disclosure
Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to
the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company represents and warrants to
the Investor, as of the date hereof, that:

 

Section 4.1 ORGANIZATION
OF THE COMPANY. The Company is
an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of
its incorporation or organization, with the requisite power and
authority to own and use its properties and assets and to carry on
its business as currently conducted. The Company is not in
violation or default of any of the provisions of its certificate of
incorporation, bylaws or other organizational or charter documents.
The Company is duly qualified to conduct business and is in good
standing as a foreign corporation in each jurisdiction in which the
nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, could not have
or reasonably be expected to result in a Material Adverse Effect
and no proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or
curtail such power and authority or qualification. The Company has
no Subsidiaries.

 

Section 4.2 AUTHORITY.
The Company has the requisite corporate power and authority to
enter into and perform its obligations under the Transaction
Documents. The execution and delivery of the Transaction Documents
by the Company and the consummation by it of the transactions
contemplated hereby and thereby have been duly authorized by all
necessary corporate action and no further consent or authorization
of the Company or its Board of Directors or stockholders is
required. The Transaction Documents have been duly executed and
delivered by the Company and constitutes a valid and binding
obligation of the Company enforceable against the Company in
accordance with its terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, or similar laws
relating to, or affecting generally the enforcement of,
creditors’ rights and remedies or by other equitable
principles of general application.

 

Section 4.3 CAPITALIZATION.
As of the date hereof, the authorized capital stock of the Company
consists of 1,000,000,000 shares of Common Stock, Common Stock, of
which approximately 873,064,371 shares of Common Stock are issued
and outstanding as of the Execution Date. The Company has not
issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise
of employee stock options under the Company’s stock option
plans, the issuance of shares of Common Stock to employees pursuant
to the Company’s employee stock purchase plans and pursuant
to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic
report under the Exchange Act. No Person has any right of first
refusal, preemptive right, right of participation, or any similar
right to participate in the transactions contemplated by the
Transaction Documents. Except as set forth in the SEC Documents,
there are no outstanding options, warrants, scrip rights to
subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into
or exercisable or exchangeable for, or giving any Person any right
to subscribe for or acquire any shares of Common Stock, or
contracts, commitments, understandings or arrangements by which the
Company is or may become bound to issue additional shares of Common
Stock or Common Stock Equivalents. The issuance and sale of the
Securities will not obligate the Company to issue shares of Common
Stock or other securities to any Person (other than the Investor)
and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under
any of such securities. There are no stockholders agreements,
voting agreements or other similar agreements with respect to the
Company’s capital stock to which the Company is a party or,
to the knowledge of the Company, between or among any of
the

 

Company’s stockholders.

 

 

 

 

Section 4.4 LISTING
AND MAINTENANCE REQUIREMENTS.
The Common Stock
is registered pursuant to Section 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its
knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the
Company received any notification that the SEC is contemplating
terminating such registration. The Company has not, in the twelve
(12) months preceding the date hereof, received notice from the
Principal Market on which the Common Stock is or has been listed or
quoted to the effect that the Company is not in compliance with the
listing or maintenance requirements of such Principal Market. The
Company is and has no reason to believe that it will not in the
foreseeable future continue to be, in compliance with all such
listing and maintenance requirements.

 

Section 4.5 SEC
DOCUMENTS; DISCLOSURE. The
Company has filed all reports, schedules, forms, statements and
other documents required to be filed by the Company under the
Securities Act and the Exchange Act, including pursuant to Section
13(a) thereof, for the one (1) year preceding the date hereof (or
such shorter period as the Company was required by law or
regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by
reference therein, being collectively referred to herein as the
“SEC Documents”)
on a timely basis or has received a valid extension of such time of
filing and has filed any such SEC Documents prior to the expiration
of any such extension. As of their respective dates, the SEC
Documents complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and
other federal laws, rules and regulations applicable to such SEC
Documents, and none of the SEC Documents when filed contained any
untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which
they were made, not misleading. The financial statements of the
Company included in the SEC Documents comply as to form and
substance in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC or
other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with
generally accepted accounting principles applied on a consistent
basis during the periods involved (except (a) as may be otherwise
indicated in such financial statements or the notes thereto or (b)
in the case of unaudited interim statements, to the extent they may
not include footnotes or may be condensed or summary statements)
and fairly present in all material respects the financial position
of the Company as of the dates thereof and the results of
operations and cash flows for the periods then ended (subject, in
the case of unaudited statements, to normal, immaterial, year-end
audit adjustments). Except with respect to the material terms and
conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other
Person acting on its behalf has provided the Investor or its agents
or counsel with any information that it believes constitutes or
might constitute material, non-public information. The Company
understands and confirms that the Investor will rely on the
foregoing representation in effecting transactions in securities of
the Company.

 

Section 4.6 VALID
ISSUANCES. The Securities are
duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly
issued, fully paid, and non-assessable, free and clear of all Liens
imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents.

 

Section 4.7 NO
CONFLICTS. The execution,
delivery and performance of the Transaction Documents by the
Company and the consummation by the Company of the transactions
contemplated hereby and thereby, including, without limitation, the
issuance of the Purchase Notice Shares, do not and will not: (a)
result in a violation of the Company’s certificate or
articles of incorporation, by-laws or other organizational or
charter documents, (b) conflict with, or constitute a material
default (or an event that with notice or lapse of time or both
would become a material default) under, result in the creation of
any Lien upon any of the properties or assets of the Company, or
give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture, instrument or any
“lock-up”
or similar provision of any underwriting or similar agreement to
which the Company is a party, or (c) result in a violation of any
federal, state or local law, rule, regulation, order, judgment or
decree (including federal and state securities laws and
regulations) applicable to the Company or by which any property or
asset of the Company is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect) nor is the Company
otherwise in violation of, conflict with or in default under any of
the foregoing. The business of the Company is not being conducted
in violation of any law, ordinance or regulation of any
governmental entity, except for possible violations that either
singly or in the aggregate do not and will not have a Material
Adverse Effect. The Company is not required under federal, state or
local law, rule or regulation to obtain any consent, authorization
or order of, or make any filing or registration with, any court or
governmental agency in order for it to execute, deliver or perform
any of its obligations under the Transaction Documents (other than
any SEC or state securities filings that may be required to be made
by the Company in connection with the issuance of Purchase Notice
Shares or subsequent to any Closing or any registration statement
that may be filed pursuant hereto); provided that, for purposes of
the representation made in this sentence, the Company is assuming
and relying upon the accuracy of the relevant representations and
agreements of Investor herein.

 

Section 4.8 NO
MATERIAL ADVERSE EFFECT. No
event has occurred that would have a Material Adverse Effect on the
Company that has not been disclosed in subsequent SEC
Documents.

 

 

 

 

Section 4.9 LITIGATION
AND OTHER PROCEEDINGS. Except
as disclosed in the SEC Documents and the Disclosure Schedule,
there are no material actions, suits, investigations, inquiries or
similar proceedings (however any governmental agency may name them)
pending or, to the knowledge of the Company, threatened against or
affecting the Company or its properties, nor has the Company
received any written or oral notice of any such action, suit,
proceeding, inquiry or investigation, which would have a Material
Adverse Effect. No judgment, order, writ, injunction or decree or
award has been issued by or, to the knowledge of the Company,
requested of any court, arbitrator or governmental agency which
would have a Material Adverse Effect. There has not been, and to
the knowledge of the Company, there is not pending or contemplated,
any investigation by the SEC involving the Company or any current
or former director or officer of the Company.

 

Section 4.10 REGISTRATION
RIGHTS. Except as set forth in
Schedule 4.10, no Person
(other than the Investor) has any right to cause the Company to
effect the registration under the Securities Act of any securities
of the Company.

 

Section 4.11 ACKNOWLEDGMENT
REGARDING INVESTOR’S PURCHASE OF SECURITIES.
The Company acknowledges and agrees that the Investor is acting
solely in the capacity of an arm’s length purchaser with
respect to the Transaction Documents and the transactions
contemplated hereby and thereby and that the Investor is not (i) an
officer or director of the Company, or (ii) an
“affiliate” (as defined in Rule 144) of the Company.
The Company further acknowledges that the Investor is not acting as
a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the
transactions contemplated hereby and thereby, and any advice given
by the Investor or any of its representatives or agents in
connection with the Transaction Documents and the transactions
contemplated hereby and thereby is merely incidental to the
Investor’s purchase of the Shares. The Company further
represents to the Investor that the Company’s decision to
enter into the Transaction Documents has been based solely on the
independent evaluation by the Company and its
representatives.

 

Section 4.12 NO
GENERAL SOLICITATION; PLACEMENT AGENT. Neither the Company,
nor any Person acting on its behalf, has engaged in any form of
general solicitation or general advertising (within the meaning of
Regulation D under the Securities act) in connection with the offer
or sale of the Securities. The Company has not engaged a placement
agent in connection with the sale of the Securities.

 

Section 4.13 NO
INTEGRATED OFFERING. None of
the Company, its affiliates, and any Person acting on their behalf
has, directly or indirectly, made any offers or sales of any
security or solicited any offers to buy any security, under
circumstances that would cause this offering of the Securities to
be integrated with prior offerings for purposes of any applicable
stockholder approval provisions, including, without limitation,
under the rules and regulations of any exchange or automated
quotation system on which any of the securities of the Company are
listed or designated, but excluding stockholder consents required
to authorize and issue the Securities or waive any anti-dilution
provisions in connection therewith.

 

Section 4.14 OTHER
COVERED PERSONS. The Company is
not aware of any Person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for
solicitation of the Investor in connection with the sale of any
Regulation D Securities.

 

 

 

 

ARTICLE V COVENANTS OF INVESTOR

 

Section 5.1 SHORT
SALES AND CONFIDENTIALITY. Neither the Investor, nor
any
affiliate of the Investor acting on its behalf or pursuant to any
understanding with it, will execute any Short Sales during the
period from the date hereof to the end of the Commitment Period.
For the purposes hereof, and in accordance with Regulation SHO, the
sale after delivery of the Purchase Notice of such number of shares
of Common Stock reasonably expected to be purchased under the
Purchase Notice shall not be deemed a Short Sale. The Investor
shall, until such time as the transactions contemplated by the
Transaction Documents are publicly disclosed by the Company in
accordance with the terms of the Transaction Documents, maintain
the confidentiality of the existence and terms of this transaction
and the information included in the Transaction
Documents.

 

Section 5.2 COMPLIANCE
WITH LAW; TRADING IN SECURITIES. The Investor’s
trading activities with respect to shares of Common Stock will be
in compliance with all applicable state and federal securities laws
and regulations and the rules and regulations of the Principal
Market.

 

ARTICLE VI COVENANTS OF THE COMPANY

 

Section 6.1 LISTING
OF COMMON STOCK. The Company
shall promptly secure the listing, where applicable, of all of the
Common Stock to be issued to the Investor hereunder on the
Principal Market (subject to official notice of issuance, where
applicable) and shall use commercially reasonable best efforts to
maintain, so long as any shares of Common Stock shall be so listed,
the listing, if required, of all such Common Stock from time
to-time issuable hereunder. The Company shall use its commercially
reasonable best efforts to continue the listing or quotation and
trading of the Common Stock on the Principal Market (including,
without limitation, maintaining sufficient net tangible assets, if
required) and will comply in all respects with the Company’s
reporting, filing and other obligations under the bylaws or rules
of the Principal Market.

 

Section 6.2 FILING
OF CURRENT REPORT AND REGISTRATION STATEMENT.
The Company agrees that it shall file a Current Report on Form 8-K,
including the Transaction Documents as exhibits thereto, with the
SEC within the time required by and in compliance with the Exchange
Act, relating to the transactions contemplated by, and describing
the material terms and conditions of, the Transaction Documents
(the “Current
Report”). The Company
shall permit the Investor to review and comment upon the final
pre-filing draft version of the Current Report at least one (1)
Business Day prior to its filing with the SEC, and the Company
shall give reasonable consideration to all such comments. The
Investor shall use its reasonable best efforts to comment upon the
final pre-filing draft version of the Current Report within one (1)
Business Day from the date the Investor receives it from the
Company. The Company shall also file with the SEC, within thirty
(30) Business Days from the Execution Date, a new Registration
Statement on Form S-1 or S-3 (the “Registration
Statement”) in compliance
with the terms of the Registration Rights Agreement, covering the
resale of the Securities.

 

 

 

 

ARTICLE VII CONDITIONS TO DELIVERY OF

 

PURCHASE NOTICE AND CONDITIONS TO CLOSING

 

Section 7.1 CONDITIONS
PRECEDENT TO THE RIGHT OF THE COMPANY TO ISSUE AND SELL
PURCHASE NOTICE SHARES. The
right of the Company to issue and sell the Purchase Notice Shares
to the Investor is subject to the satisfaction of each of the
conditions set forth below:

 

(a) ACCURACY OF INVESTOR’S REPRESENTATIONS AND
WARRANTIES.
The representations and warranties of
the Investor shall be true and correct in all material respects as
of the date of this Agreement and as of the date of each Closing as
though made at each such time.

 

(b) PERFORMANCE BY
INVESTOR. Investor shall have
performed, satisfied
and complied in all respects with all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or
complied with by the Investor at or prior to such
Closing.

 

(c) PERFORMANCE BY
INVESTOR. Investor shall have
performed, satisfied
and complied in all respects with all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or
complied with by the Investor at or prior to such
Closing.

 

(d) PRINCIPAL
MARKET REGULATION. The Company
shall not issue
any Purchase Notice Shares, and the Investor shall not have the
right to receive any Purchase Notice Shares, if the issuance of
such Purchase Notice Shares would exceed the aggregate number of
shares of Common Stock which the Company may issue without
breaching the Company’s obligations under the rules or
regulations of the Principal Market.

 

Section 7.2 CONDITIONS
PRECEDENT TO THE OBLIGATION OF INVESTOR TO PURCHASE THE
PURCHASE NOTICE SHARES. The
obligation of the Investor hereunder to purchase the Purchase
Notice Shares is subject to the satisfaction of each of the
following conditions:

 

(a) *intentionally
omitted*

 

(b) EFFECTIVE
REGISTRATION STATEMENT. The
Registration Statement,
and any amendment or supplement thereto, shall remain effective for
the offering of the Securities and (i) the Company shall not have
received notice that the SEC has issued or intends to issue a stop
order with respect to such Registration Statement or that the SEC
otherwise has suspended or withdrawn the effectiveness of such
Registration Statement, either temporarily or permanently, or
intends or has threatened to do so and (ii) no other suspension of
the use of, or withdrawal of the effectiveness of, such
Registration Statement or related prospectus shall exist. The
Investor shall not have received any notice from the Company that
the prospectus and/or any prospectus supplement fails to meet the
requirements of Section 5(b) or Section 10 of the Securities
Act.

 

 

 

 

(c) ACCURACY
OF THE COMPANY’S REPRESENTATIONS AND WARRANTIES.
The representations and warranties of
the Company shall be true and correct in all material respects as
of the date of this Agreement and as of the date of each Closing
(except for representations and warranties specifically made as of
a particular date).

 

(d) PERFORMANCE
BY THE COMPANY. The Company
shall have
performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by this Agreement to
be performed, satisfied or complied with by the
Company.

 

(e) NO INJUNCTION.
No statute, rule, regulation,
executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated
or adopted by any court or governmental authority of competent
jurisdiction that prohibits or directly and materially adversely
affects any of the transactions contemplated by the Transaction
Documents, and no proceeding shall have been commenced that may
have the effect of prohibiting or materially adversely affecting
any of the transactions contemplated by the Transaction
Documents.

 

(f) ADVERSE
CHANGES. Since the date of
filing of the Company’s most
recent annual report on Form 10-K, no event that had or is
reasonably likely to have a Material Adverse Effect has
occurred.

 

(g) NO
SUSPENSION OF TRADING IN OR DELISTING OF COMMON STOCK.
The trading of the Common Stock shall
not have been suspended by the SEC or the Principal Market, or
otherwise halted for any reason, and the Common Stock shall have
been approved for listing or quotation on and shall not have been
delisted from or no longer quoted on the Principal Market. In the
event of a suspension, delisting, or halting for any reason, of the
trading of the Common Stock, as contemplated by this Section
7.2(g), the Investor shall have the right to return to the Company
any amount of Purchase Notice Shares associated with such Purchase
Notice, and the Investment Amount with respect to such Purchase
Notice shall be refunded accordingly.

 

(h) BENEFICIAL
OWNERSHIP LIMITATION. The
number of Purchase
Notice Shares then to be purchased by the Investor shall not exceed
the number of such shares that, when aggregated with all other
shares of Common Stock then owned by the Investor beneficially or
deemed beneficially owned by the Investor, would result in the
Investor owning more than the Beneficial Ownership Limitation (as
defined below), as determined in accordance with Section 13 of the
Exchange Act. For purposes of this Section 7.2(h), in the event
that the amount of Common Stock outstanding is greater or lesser on
a Closing Date than on the date upon which the Purchase Notice
associated with such Closing Date is given, the amount of Common
Stock outstanding on such issuance of a Purchase Notice shall
govern for purposes of determining whether the Investor, when
aggregating all purchases of Common Stock made pursuant to this
Agreement, would own more than the Beneficial Ownership Limitation
following a purchase on any such Closing Date. In the event the
Investor claims that compliance with a Purchase Notice would result
in the Investor owning more than the Beneficial Ownership
Limitation, upon request of the Company the Investor will provide
the Company with evidence of the Investor’s then existing
shares beneficially or deemed beneficially owned. The
“Beneficial Ownership Limitation” shall be 4.99% of the
number of shares of the Common Stock outstanding immediately prior
to the issuance of shares of Common Stock issuable pursuant to a
Purchase Notice. Notwithstanding the foregoing, the Investor may
increase the Beneficial Ownership Limitation up to 9.99% at its
sole discretion. To the extent that the Beneficial Ownership
Limitation is exceeded, the number of shares of Common Stock
issuable to the Investor shall be reduced so it does not exceed the
Beneficial Ownership Limitation.

 

 

 

 

(i) [INTENTIONALLY
OMITTED]

 

(j) NO
KNOWLEDGE. The Company shall
have no knowledge of any event more likely than not to have the
effect of causing the effectiveness of the Registration Statement
to be suspended or any prospectus or prospectus supplement failing
to meet the requirement of Sections 5(b) or 10 of the Securities
Act (which event is more likely than not to occur within the
fifteen (15) Business Days following the Business Day on which such
Purchase Notice is deemed delivered).

 

(k) NO VIOLATION
OF
SHAREHOLDER APPROVAL REQUIREMENT.
The issuance of the Purchase Notice
Shares shall not violate the shareholder approval requirements of
the Principal Market.

 

(l) DWAC ELIGIBLE.
The Common Stock must be DWAC Eligible
and not subject to a “DTC chill”.

 

(m) SEC DOCUMENTS.
All reports, schedules, registrations,
forms, statements, information and other documents required to have
been filed by the Company with the SEC pursuant to the reporting
requirements of the Exchange Act shall have been filed with the SEC
within the applicable time periods prescribed for such filings
under the Exchange Act.

 

ARTICLE VIII LEGENDS

 

Section 8.1 NO
RESTRICTIVE STOCK LEGEND. No
restrictive stock legend shall be placed on the share certificates
representing the Purchase Notice Shares.

 

Section 8.2 INVESTOR’S
COMPLIANCE. Nothing in this
Article VIII shall affect in any way the Investor’s
obligations hereunder to comply with all applicable securities laws
upon the sale of the Common Stock.

 

ARTICLE IX INDEMNIFICATION

 

Section 9.1 INDEMNIFICATION.
Each party (an “Indemnifying
Party”) agrees to
indemnify and hold harmless the other party along with its
officers, directors, employees, and authorized agents, and each
Person or entity, if any, who controls such party within the
meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act (an “Indemnified
Party”) from and against
any Damages, and any action in respect thereof to which the
Indemnified Party becomes subject to, resulting from, arising out
of this Agreement or relating to (i) any misrepresentation, breach
of warranty or nonfulfillment of or failure to perform any covenant
or agreement on the part of the Indemnifying Party contained in
this Agreement, (ii) any untrue statement or alleged untrue
statement of a material fact contained in the Registration
Statement or any post-effective amendment thereof or prospectus or
prospectus supplement, or the omission or alleged omission
therefrom of a material fact required to be stated therein or
necessary to make the statements therein not misleading, (iii) any
untrue statement or alleged untrue statement of a material fact
contained in any preliminary prospectus or contained in the final
prospectus (as amended or supplemented, if the Company files any
amendment thereof or supplement thereto with the SEC) or the
omission or alleged omission to state therein any material fact
necessary to make the statements made therein, in the light of the
circumstances under which the statements therein were made, not
misleading, or (iv) any violation or alleged violation by the
Company of the Securities Act, the Exchange Act, any state
securities law or any rule or regulation under the Securities Act,
the Exchange Act or any state securities law, as such Damages are
incurred, except to the extent such Damages result primarily from
the Indemnified Party’s failure to perform any covenant or
agreement contained in this Agreement or the Indemnified
Party’s, recklessness or willful misconduct in performing its
obligations under this Agreement; provided,
however, that the foregoing
indemnity agreement shall not apply to any Damages of an
Indemnified Party to the extent, but only to the extent, arising
out of or based upon any untrue statement or alleged untrue
statement or omission or alleged omission made by an Indemnifying
Party in reliance upon and in conformity with written information
furnished to the Indemnifying Party by the Indemnified Party
expressly for use in the Registration Statement, any post-effective
amendment thereof, prospectus, prospectus supplement thereto, or
any preliminary prospectus or final prospectus (as amended or
supplemented).

 

 

 

 

Section 9.2 INDEMNIFICATION
PROCEDURE.

 

(a)  A party that seeks indemnification under must
promptly give the other
party notice of any legal action. But a delay in notice does not
relieve an Indemnifying Party of any liability to any Indemnified
Party, except to the extent the Indemnifying Party shows that the
delay prejudiced the defense of the action.

 

(b)  The Indemnifying Party may participate in the
defense at any time or
it may assume the defense by giving notice to the Indemnified
Parties. After assuming the defense, the Indemnifying
Party

 

(i) must
select counsel (including local counsel if
appropriate) that
is reasonably satisfactory to the Indemnified Parties;

 

(ii)
is not liable to the other party for
any later attorney’s fees or
for any other later expenses that the Indemnified Parties incur,
except for reasonable investigation costs;

 

(iii) must
not compromise or settle the action without the Indemnified Parties
consent (which may not be unreasonably withheld); and

 

(iv) is
not liable for any compromise or settlement made
without
its consent.

 

(c)  If the Indemnifying Party fails to assume the
defense within 10 days
after receiving notice of the action, the Indemnifying Party shall
be bound by any determination made in the action or by any
compromise or settlement made by the Indemnified Parties, and also
remains liable to pay the Indemnified Parties’ legal fees and
expenses.

  

Section 9.3 METHOD
OF ASSERTING INDEMNIFICATION CLAIMS. All claims for
indemnification by any Indemnified Party under Section 9.2 shall be
asserted and resolved as follows:

 

(a) In
the event any claim or demand in respect of which an Indemnified
Party might seek indemnity under Section 9.2 is asserted against or
sought to be collected from such Indemnified Party by a Person
other than a party hereto or an affiliate thereof (a “Third
Party Claim”), the Indemnified Party shall deliver a written
notification, enclosing a copy of all papers served, if any, and
specifying the nature of and basis for such Third Party Claim and
for the Indemnified Party’s claim for indemnification that is
being asserted under any provision of Section 9.2 against an
Indemnifying Party, together with the amount or, if not then
reasonably ascertainable, the estimated amount, determined in good
faith, of such Third Party Claim (a “Claim Notice”)
with reasonable promptness to the Indemnifying Party. If the
Indemnified Party fails to provide the Claim Notice with reasonable
promptness after the Indemnified Party receives notice of such
Third Party Claim, the Indemnifying Party shall not be obligated to
indemnify the Indemnified Party with respect to such Third Party
Claim to the extent that the Indemnifying Party’s ability to
defend has been prejudiced by such failure of the Indemnified
Party. The Indemnifying Party shall notify the Indemnified Party as
soon as practicable within the period ending thirty (30) calendar
days following receipt by the Indemnifying Party of either a Claim
Notice or an Indemnity Notice (as defined below) (the
“Dispute Period”) whether the Indemnifying Party
disputes its liability or the amount of its liability to the
Indemnified Party under Section 9.2 and whether the Indemnifying
Party desires, at its sole cost and expense, to defend the
Indemnified Party against such Third Party Claim.

 

(i) 
If the Indemnifying Party notifies the
Indemnified Party within the Dispute Period that the Indemnifying
Party desires to defend the Indemnified Party with respect to the
Third Party Claim pursuant to this Section 9.3(a), then the
Indemnifying Party shall have the right to defend, with counsel
reasonably satisfactory to the Indemnified Party, at the sole cost
and expense of the Indemnifying Party, such Third Party Claim by
all appropriate proceedings, which proceedings shall be vigorously
and diligently prosecuted by the Indemnifying Party to a final
conclusion or will be settled at the discretion of the Indemnifying
Party (but only with the consent of the Indemnified Party in the
case of any settlement that provides for any relief other than the
payment of monetary damages or that provides for the payment of
monetary damages as to which the Indemnified Party shall not be
indemnified in full pursuant to Section 9.2). The Indemnifying
Party shall have full control of such defense and proceedings,
including any compromise or settlement thereof;
provided,
however, that the Indemnified Party may, at the sole cost and
expense of the Indemnified Party, at any time prior to the
Indemnifying Party’s delivery of the notice referred to in
the first sentence of this clause (i), file any motion, answer or
other pleadings or take any other action that the Indemnified Party
reasonably believes to be necessary or appropriate to protect its
interests; and provided,
further,
that if requested by the Indemnifying Party, the Indemnified Party
will, at the sole cost and expense of the Indemnifying Party,
provide reasonable cooperation to the Indemnifying Party in
contesting any Third Party Claim that the Indemnifying Party elects
to contest. The Indemnified Party may participate in, but not
control, any defense or settlement of any Third Party Claim
controlled by the Indemnifying Party pursuant to this clause (i),
and except as provided in the preceding sentence, the Indemnified
Party shall bear its own costs and expenses with respect to such
participation. Notwithstanding the foregoing, the Indemnified Party
may take over the control of the defense or settlement of a Third
Party Claim at any time if it irrevocably waives its right to
indemnity under Section 9.2 with respect to such Third Party
Claim.

 

 

 

 

(ii) If
the Indemnifying Party fails to notify the Indemnified Party within
the Dispute Period that the Indemnifying Party desires to defend
the Third Party Claim pursuant to Section 9.3(a), or if the
Indemnifying Party gives such notice but fails to prosecute
vigorously and diligently or settle the Third Party Claim, or if
the Indemnifying Party fails to give any notice whatsoever within
the Dispute Period, then the Indemnified Party shall have the right
to defend, at the sole cost and expense of the Indemnifying Party,
the Third Party Claim by all appropriate proceedings, which
proceedings shall be prosecuted by the Indemnified Party in a
reasonable manner and in good faith or will be settled at the
discretion of the Indemnified Party(with the consent of the
Indemnifying Party, which consent will not be unreasonably
withheld). The Indemnified Party will have full control of such
defense and proceedings, including any compromise or settlement
thereof; provided, however, that if requested by the Indemnified
Party, the Indemnifying Party will, at the sole cost and expense of
the Indemnifying Party, provide reasonable cooperation to the
Indemnified Party and its counsel in contesting any Third Party
Claim which the Indemnified Party is contesting. Notwithstanding
the foregoing provisions of this clause (ii), if the Indemnifying
Party has notified the Indemnified Party within the Dispute Period
that the Indemnifying Party disputes its liability or the amount of
its liability hereunder to the Indemnified Party with respect to
such Third Party Claim and if such dispute is resolved in favor of
the Indemnifying Party in the manner provided in clause (iii)
below, the Indemnifying Party will not be required to bear the
costs and expenses of the Indemnified Party’s defense
pursuant to this clause (ii) or of the Indemnifying Party’s
participation therein at the Indemnified Party’s request, and
the Indemnified Party shall reimburse the Indemnifying Party in
full for all reasonable costs and expenses incurred by the
Indemnifying Party in connection with such litigation. The
Indemnifying Party may participate in, but not control, any defense
or settlement controlled by the Indemnified Party pursuant to this
clause (ii), and the Indemnifying Party shall bear its own costs
and expenses with respect to such participation.

 

(iii)           If
the Indemnifying Party notifies the Indemnified Party
that it does not dispute its liability or the
amount of its liability to the Indemnified Party with respect to
the Third Party Claim under Section 9.2 or fails to notify the
Indemnified Party within the Dispute Period whether the
Indemnifying Party disputes its liability or the amount of its
liability to the Indemnified Party with respect to such Third Party
Claim, the amount of Damages specified in the Claim Notice shall be
conclusively deemed a liability of the Indemnifying Party under
Section 9.2 and the Indemnifying Party shall pay the amount of such
Damages to the Indemnified Party on demand. If the Indemnifying
Party has timely disputed its liability or the amount of its
liability with respect to such claim, the Indemnifying Party and
the Indemnified Party shall proceed in good faith to negotiate a
resolution of such dispute; provided,
however,
that if the dispute is not resolved within thirty (30) days after
the Claim Notice, the Indemnifying Party shall be entitled to
institute such legal action as it deems
appropriate.

 

(b) In
the event any Indemnified Party should have a claim under Section
9.2 against the Indemnifying Party that does not involve a Third
Party Claim, the Indemnified Party shall deliver a written
notification of a claim for indemnity under Section 9.2 specifying
the nature of and basis for such claim, together with the amount
or, if not then reasonably ascertainable, the estimated amount,
determined in good faith, of such claim (an “Indemnity
Notice”) with reasonable promptness to the Indemnifying
Party. The failure by any Indemnified Party to give the Indemnity
Notice shall not impair such party’s rights hereunder except
to the extent that the Indemnifying Party demonstrates that it has
been irreparably prejudiced thereby. If the Indemnifying Party
notifies the Indemnified Party that it does not dispute the claim
or the amount of the claim described in such Indemnity Notice or
fails to notify the Indemnified Party within the Dispute Period
whether the Indemnifying Party disputes the claim or the amount of
the claim described in such Indemnity Notice, the amount of Damages
specified in the Indemnity Notice will be conclusively deemed a
liability of the Indemnifying Party under Section 9.2 and the
Indemnifying Party shall pay the amount of such Damages to the
Indemnified Party on demand. If the Indemnifying Party has timely
disputed its liability or the amount of its liability with respect
to such claim, the Indemnifying Party and the Indemnified Party
shall proceed in good faith to negotiate a resolution of such
dispute; provided, however, that if the dispute is not resolved
within thirty (30) days after the Claim Notice, the Indemnifying
Party shall be entitled to institute such legal action as it deems
appropriate.

 

(c) The
Indemnifying Party agrees to pay the Indemnified Party,
promptly
as such expenses are incurred and are due and payable, for any
reasonable legal fees or other reasonable expenses incurred by them
in connection with investigating or defending any such
Claim.

 

(d) The
indemnity provisions contained herein shall be in addition to (i)
any cause of action or similar rights of the Indemnified Party
against the Indemnifying Party or others, and (ii) any liabilities
the Indemnifying Party may be subject to.

 

 

 

 

ARTICLE X MISCELLANEOUS

 

Section 10.1 GOVERNING
LAW; JURISDICTION. This
Agreement shall be governed by and interpreted in accordance with
the laws of the State of California without regard to the
principles of conflicts of law. Each of the Company and the
Investor hereby submits to the exclusive jurisdiction of the United
States federal and state courts located in Los Angeles, California,
with respect to any dispute arising under the Transaction Documents
or the transactions contemplated thereby.

 

Section 10.2 JURY
TRIAL WAIVER. The Company and
the Investor hereby waive a trial by jury in any action, proceeding
or counterclaim brought by either of the parties hereto against the
other in respect of any matter arising out of or in connection with
the Transaction Documents.

 

Section 10.3 ASSIGNMENT.
The Transaction Documents shall be binding upon and inure to the
benefit of the Company and the Investor and their respective
successors. Neither this Agreement nor any rights of the Investor
or the Company hereunder may be assigned by either party to any
other Person.

 

Section 10.4 NO
THIRD-PARTY BENEFICIARIES. This
Agreement is intended for the benefit of the Company and the
Investor and their respective successors, and is not for the
benefit of, nor may any provision hereof be enforced by, any other
Person, except as contemplated by Article IX.

 

Section 10.5 TERMINATION.
The Company or Investor may terminate
this Agreement at any time in the event of a material breach of the
Agreement by the Company or Investor, which shall be effected by
written notice being sent by the non-breaching party to the
breaching party. In addition, this Agreement shall automatically
terminate on the earlier of (i) the end of the Commitment Period;
(ii) the date in which the Registration Statement is no longer
effective, or (iii) the date that, pursuant to or within the
meaning of any Bankruptcy Law, the Company commences a voluntary
case or any Person commences a proceeding against the Company, a
Custodian is appointed for the Company or for all or substantially
all of its property or the Company makes a general assignment for
the benefit of its creditors (the “Automatic Termantion
Date”); provided, however, that the provisions of Articles
III, IV, V, VI, IX and the agreements and covenants of the Company
and the Investor set forth in this Article X shall survive the
termination of this Agreement. If the Company terminates the
Agreement prior to the Automatic Termination Date, the Company
shall wire $50,000 to the Investor irrespective of any other event
or condition, including, without limitation, the Company’s
submission of a Purchase Notice.

 

Section 10.6 ENTIRE
AGREEMENT. The Transaction
Documents, together with the exhibits thereto, contain the entire
understanding of the Company and the Investor with respect to the
matters covered herein and therein and supersede all prior
agreements and understandings, oral or written, with respect to
such matters, which the parties acknowledge have been merged into
such documents and exhibits.

 

Section 10.7 FEES
AND EXPENSES. Except as
expressly set forth in the Transaction Documents or any other
writing to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any,
and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of
this Agreement. The Company shall pay the Clearing Cost associated
with each Closing, and any Transfer Agent fees (including any fees
required for same-day processing of any instruction letter
delivered by the Company), stamp taxes and other taxes and duties
levied in connection with the delivery of any Securities to the
Investor.

 

 

 

 

Section 10.8 COUNTERPARTS.
The Transaction Documents may be executed in multiple counterparts,
each of which may be executed by less than all of the parties and
shall be deemed to be an original instrument which shall be
enforceable against the parties actually executing such
counterparts and all of which together shall constitute one and the
same instrument. The Transaction Documents may be delivered to the
other parties hereto by email of a copy of the Transaction
Documents bearing the signature of the parties so delivering this
Agreement.

 

Section 10.9 SEVERABILITY.
In the event that any provision of this Agreement becomes or is
declared by a court of competent jurisdiction to be illegal,
unenforceable or void, this Agreement shall continue in full force
and effect without said provision; provided that such severability
shall be ineffective if it materially changes the economic benefit
of this Agreement to any party.

 

Section 10.10 FURTHER
ASSURANCES. Each party shall do
and perform, or cause to be done and performed, all such further
acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as the other
party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of
the transactions contemplated hereby.

 

Section 10.11 NO
STRICT CONSTRUCTION. The
language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any
party.

 

Section 10.12 EQUITABLE
RELIEF. The Company recognizes
that in the event that it fails to perform, observe, or discharge
any or all of its obligations under this Agreement, any remedy at
law may prove to be inadequate relief to the Investor. The Company
therefore agrees that the Investor shall be entitled to temporary
and permanent injunctive relief in any such case without the
necessity of proving actual damages. In addition to being entitled
to exercise all rights provided herein or granted by law, both
parties will be entitled to specific performance under the
Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any
breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any action for specific
performance of any such obligation the defense that a remedy at law
would be adequate.

 

Section 10.13 TITLE
AND SUBTITLES. The titles and
subtitles used in this Agreement are used for the convenience of
reference and are not to be considered in construing or
interpreting this Agreement.

 

Section 10.14 AMENDMENTS;
WAIVERS. No provision of this
Agreement may be amended or waived by the parties from and after
the date that is one (1) Business Day immediately preceding the
initial filing of the prospectus to the Registration Statement with
the SEC. Subject to the immediately preceding sentence, (i) no
provision of this Agreement may be amended other than by a written
instrument signed by both parties hereto and (ii) no provision of
this Agreement may be waived other than in a written instrument
signed by the party against whom enforcement of such waiver is
sought. No failure or delay in the exercise of any power, right or
privilege hereunder shall operate as a waiver thereof, nor shall
any single or partial exercise of any such power, right or
privilege preclude other or further exercise thereof or of any
other right, power or privilege.

 

Section 10.15 PUBLICITY.
The Company and the Investor shall consult with each other in
issuing any press releases or otherwise making public statements
with respect to the transactions contemplated hereby and no party
shall issue any such press release or otherwise make any such
public statement, other than as required by law, without the prior
written consent of the other parties, which consent shall not be
unreasonably withheld or delayed, except that no prior consent
shall be required if such disclosure is required by law, in which
such case the disclosing party shall provide the other party with
prior notice of such public statement. Notwithstanding the
foregoing, the Company shall not publicly disclose the name of the
Investor without the prior written consent of the Investor, except
to the extent required by law. The

 

Investor acknowledges that the Transaction Documents may be deemed
to be “material contracts,”
as that term is defined by Item 601(b)(10) of Regulation S-K, and
that the Company may therefore be required to file such documents
as exhibits to reports or registration statements filed under the
Securities Act or the Exchange Act. The Investor further agrees
that the status of such documents and materials as material
contracts shall be determined solely by the Company, in
consultation with its counsel.

 

 

 

 

Section 10.16 DISPUTE
RESOLUTION.                                                                                                 

 

(a)

Submission to Dispute
Resolution.

 

(i) In
the case of a dispute relating to the Average Daily Trading Volume,
Purchase Notice Limit or VWAP (as the case may be) (including,
without limitation, a dispute relating to the determination of any
of the foregoing), the Company or the Investor (as the case may be)
shall submit the dispute to the other party via facsimile or
electronic mail (A) if by the Company, within two (2) Business Days
after the occurrence of the circumstances giving rise to such
dispute or (B) if by the Investor at any time after the Investor
learned of the circumstances giving rise to such dispute. If the
Investor and the Company are unable to promptly resolve such
dispute relating to such Average Daily Trading Volume, Purchase
Notice Limit or VWAP (as the case may be), at any time after the
second (2nd) Business Day following such initial notice by the
Company or the Investor (as the case may be) of such dispute to the
Company or the Investor (as the case may be), then the Company and
the Investor may select an independent, reputable investment bank
as mutually agreed upon to resolve such dispute.

 

(ii) The
Investor and the Company shall each deliver to such investment bank
(A) a copy of the initial dispute submission so delivered in
accordance with the first sentence of this Section 10.16 and (B)
written documentation supporting its position with respect to such
dispute, in each case, no later than 5:00 p.m. (New York time) by
the fifth (5th) Business Day immediately following the date on
which such investment bank was selected (the “Dispute
Submission Deadline”) (the documents referred to in the
immediately preceding clauses (A) and (B) are collectively referred
to herein as the “Required Dispute Documentation”) (it
being understood and agreed that if either the Investor or the
Company fails to so deliver all of the Required Dispute
Documentation by the Dispute Submission Deadline, then the party
who fails to so submit all of the Required Dispute Documentation
shall no longer be entitled to (and hereby waives its right to)
deliver or submit any written documentation or other support to
such investment bank with respect to such dispute and such
investment bank shall resolve such dispute based solely on the
Required Dispute Documentation that was delivered to such
investment bank prior to the Dispute Submission Deadline). Unless
otherwise agreed to in writing by both the Company and the Investor
or otherwise requested by such investment bank, neither the Company
nor the Investor shall be entitled to deliver or submit any written
documentation or other support to such investment bank in
connection with such dispute (other than the Required Dispute
Documentation).

 

(iii) The
Company and the Investor shall cause such investment bank to
determine the resolution of such dispute and notify the Company and
the Investor of such resolution no later than ten (10) Business
Days immediately following the Dispute Submission Deadline. The
fees and expenses of such investment bank shall be borne solely by
the party submitting such dispute, and such investment bank’s
resolution of such dispute shall be final and binding upon all
parties absent manifest error.

 

(b) Miscellaneous.
Both the Company and the Investor
expressly acknowledge and agree that (i) this Section 10.16
constitutes an agreement to arbitrate between the Company and the
Investor (and constitutes an arbitration agreement) only with
respect to such dispute in connection with Section 10.16(a)(i) and
that both the Company and the Investor are authorized to apply for
an order to compel arbitration in order to compel compliance with
this Section 10.16, (ii) the terms of this Agreement and each other
applicable Transaction Document shall serve as the basis for the
selected investment bank’s resolution of the applicable
dispute, such investment bank shall be entitled (and is hereby
expressly authorized) to make all findings, determinations and the
like that such investment bank determines are required to be made
by such investment bank in connection with its resolution of such
dispute and in resolving such dispute such investment bank shall
apply such findings, determinations and the like to the terms of
this Agreement and any other applicable Transaction Documents,
(iii) the Company and the Investor shall have the right to submit
any dispute other than described in this Section 10.16 (a) to any
state or federal court sitting in The City of Los Angeles and (iv)
nothing in this Section 10.16 shall limit the Company or the
Investor from obtaining any injunctive relief or other equitable
remedies (including, without limitation, with respect to any
matters described in this Section 10.16). The Company and the
Investor agree that all dispute resolutions may be conducted in a
virtual setting to be mutually agreed by both
parties.

 

 

 

 

Section 10.17 NOTICES.
All notices, demands, requests, consents, approvals, and other
communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (a) personally
served, (b) delivered by reputable air courier service with charges
prepaid next Business Day delivery, or (c) transmitted by hand
delivery, or email as a PDF, addressed as set forth below or to
such other address as such party shall have specified most recently
by written notice given in accordance herewith. Any notice or other
communication required or permitted to be given hereunder shall be
deemed effective upon hand delivery or delivery by email at the
address designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is
to be received).

 

The
addresses for such communications shall be:

 

If
to the Company:

 

TPT
Global Tech, Inc.

 

Email:
stephen@tptglobaltech.com

 

with
a copy (not constituting notice) to:

 

Email:

 

If
to the Investor:

 

WHITE
LION CAPITAL LLC

 

Email:
team@whitelioncapital.com

 

Either party hereto may from time to time change its address or
email for notices under this Section 10.17 by giving prior written
notice of such changed address to the other party
hereto.

 

 

 

[Signature Page Follows]

 

 

 

 

IN WITNESS WHEREOF, the parties
have caused this Agreement to be duly executed by their respective
officers thereunto duly authorized as of the day and year first
above written.

 

	
 

	

TPT Global Tech, Inc

	
 

	
 

	
 

	
 

	
 

	
 

	
 By:

	
 

	
 

	
 

	
 Name:

	
Stephen
Thomas

	
Title:

	
Chief
Executive Officer

 

 
	
 

	

WHITE
LION CAPITAL LLC

	
 

	
 

	
 

	 
	
 

	
 

	
 By:

	

	
 

	
 

	
 Name:

	

Yash Thukral

	
Title:
 

	

Managing Director

 

 

 

 

DISCLOSURE SCHEDULES TO

 

COMMON STOCK PURCHASE AGREEMENT

 

Schedule 4.5 – SEC Documents

 

Schedule 4.9 – Litigation

 

Schedule 4.10 – Registration Rights

 

 

 

 

 

EXHIBIT A FORM OF PURCHASE NOTICE

 

TO: WHITE LION CAPITAL LLC

 

We
refer to the Common Stock Purchase Agreement, dated as of 28 May,
2021, (the “Agreement”),
entered into by and between TPT Global Tech, Inc. and White Lion
Capital LLC. Capitalized terms defined in the Agreement shall,
unless otherwise defined herein, have the same meaning when used
herein.

 

We hereby:

 

 

1)

Give
you notice that we require you to purchase __________ Purchase
Notice Shares; and

 

 

2)

Certify
that, as of the date hereof, the conditions set forth in Section 7
of the Agreement are satisfied.

 

 

 

 

	

 

	
TPT
Global Tech, Inc.

	

 

	

 

	

 

	

 

	

 

	

	
By:  

	
/s/ 

	

 

	

 

	

 

	
Name:
Stephen
Thomas

	

 

	

 

	

 

	

Title:
Chief
Executive Officer

	

 

 

 

 

 

EXHIBIT B

 

FIXED PURCHASE NOTICE

 

 

TO: WHITE LION CAPITAL LLC

 

We
refer to the Common Stock Purchase Agreement, dated as of May 28,
2021 (the “Agreement”),
entered into by and between TPT Global Tech, Inc., and White Lion
Capital LLC. Capitalized terms defined in the Agreement shall,
unless otherwise defined herein, have the same meaning when used
herein.

 

 

We hereby:

 

 

1) Certify that, as of the date hereof, the conditions set forth in
Section 7 of the Agreement are satisfied.

 

 

The Company and Investor agree to as follows:

 

 

Purchase Price:

 

Share Amount:

 

 

	
 

	

TPT
Global Tech, Inc

	
 

	
 

	
 

	 
	
 

	
 

	
 By:

	
 

	
 

	
 

	
 Name:

	
Stephen
Thomas

	
Title:
 

	
 Chief
Executive Officer

 

 

	
 

	

WHITE
LION CAPITAL LLC

	
 

	
 

	
 

	 
	
 

	
 

	
 By:

	
 

	
 

	
 

	
 Name:

	

Yash Thukral

	
Title:
 

	

Managing Director

 

 

 

 

 

EXHIBIT C

 

REGISTRATION RIGHTS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]